AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05507892 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Aminohippurate Sodium Inj 20%
Description: Diagnostic aid/agent used to measure renal plasma flow (RPF) PAH (Basic Pharma, Geleen, Netherlands) has been used to measure RPF in human research for 7 decades, and is very well tolerated and generally recognized as safe with low toxicity.
Study NCT06539377 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Living donor liver transplantation
Description: Liver transplantation from living donor donation (SII/III as left-lateral donation during a two stage-procedure or left lobe donation or right lobe donation) in patients with unresectable intrahepatic cholangiocarcinoma.
Study NCT06326151 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Interdisciplinary Psychoeducational Programme
Description: This intervention is based on the principle of complementing and integrating both disciplines in order to meet the psychological needs of family carers and to train them in knowledge and strategies aimed at the correct performance of activities of daily living in order to promote the maximum autonomy and functionality of dependent people with cognitive impairment, and that this favours discharge, self-care, improvement of the affective state and quality of life of family carers.
Study NCT06326151 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Health Education Programme
Description: Upon discharge from the hospital, at the end of the baseline assessment, caregivers will receive instructions and recommendations for maintaining an active and healthy lifestyle. This will be done by encouraging self-care and good practices in caring for their dependent family member, as part of a health education programme. The benefits of an active lifestyle and general guidelines are emphasized.
Study NCT05597046 — intervention group
Intervention type: OTHER
Intervention: Interview
Description: Interviews
Study NCT05590403 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: RSVPreF3 OA investigational vaccine
Description: One dose administered intramuscularly at Day 1.
Study NCT05590403 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: One dose administered intramuscularly at Day 1.
Study NCT04727216 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Dorsal Root Ganglion Stimulation (DRG-S)
Description: Dorsal Root Ganglion stimulation will be delivered with continuous dosing and 2 different ON/OFF periods to compare effects for each patient.
Study NCT04727216 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Dorsal Root Ganglion Stimulation (DRG-S)
Description: Dorsal Root Ganglion stimulation will be delivered with continuous dosing and 2 different ON/OFF periods to compare effects for each patient.
Study NCT04892446 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Magrolimab
Description: Administered IV
Study NCT05158803 — intervention group
Intervention type: RADIATION
Intervention: ultrasound and C.T
Description: lung ultrasound in comparison to C.T
Study NCT04957524 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: iStim TENS unit and Transvaginal Probe
Description: iStim TENS unit and Transvaginal Probe are both commercially available products. TENS units work by delivering small electrical impulses through electrodes either attached to the skin or through a transvaginal probe.~iStim transvaginal probe will be inserted vaginally to provide transvaginal electrical stimulation.
Study NCT04957524 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: iStim TENS unit and Transvaginal Probe
Description: iStim TENS unit and Transvaginal Probe are both commercially available products. TENS units work by delivering small electrical impulses through electrodes either attached to the skin or through a transvaginal probe.~iStim transvaginal probe will be inserted vaginally to provide transvaginal electrical stimulation.
Study NCT05225168 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: laparoscopic burch colposuspension operation
Description: By pushing the urethra medially, two sutures are placed on the bladder at trigon level and midurethral and suspended on the bilateral iliopectineal ligament and colposuspension is supplied.
Study NCT05225168 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: minisling suburethral sling
Description: A vertical vaginal incision is made 1 cm below the external urethral meatus. It is followed by minimal vaginal dissection from the inferior portion of the ascending ramus of the ischiopubic bone to the obturator muscle. The arms of the mesh are fixed on both sides of the obturator internus muscle with the help of a trocar. After leaving a 1-2 mm gap between the mesh and the urethra, the vaginal wall is closed by suturing.
Study NCT04521166 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Hearing aid
Description: Settings in a wearable hearing aid will be adjusted within a clinically-relevant range for two features. The features include wide dynamic range compression and microphone directionality.
Study NCT06482424 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: intervention group
Description: Actions to be taken to the Intervention Group The researcher will record the state-trait anxiety scale and Pittsburg Sleep Quality Index score on the patient follow-up chart-researcher form at the patient's home at the beginning of the first week and at the end of the fourth week. The aromatic oil given to patients in the intervention group will be placed in 10ml dark glass bottles with droppers and a numbered label will be attached to the bottle.~Procedures to be Performed on the Placebo Group The researcher will record the state-trait anxiety scale and Pittsburg Sleep Quality Index score on the patient follow-up chart-researcher form at the patient's home at the beginning of the first week and at the end of the fourth week. Sesame oil given to patients in the placebo group will be placed in 10 ml dark glass bottles with droppers and a number two label will be attached to the bottle.
Study NCT06468475 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Magnesium Sulphate infusion
Description: Magnesium sulphate 24 hours apart by intravenous infusion at 250 mg/kg/dose (0.5 mL/kg/dose of injection magnesium sulphate 50% w/v diluted in 5 mL/kg of 5% glucose) over a duration of half an hour by an infusion pump
Study NCT04333459 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Hataan DNA Vaccine/Puumala DNA Vaccine
Description: Vaccine compared in High and Lose Doses.
Study NCT04773977 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IBI362 liquid formulation
Description: Administered by subcutaneous injection
Study NCT04773977 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IBI362 lyophilized powder
Description: Administered by subcutaneous injection
Study NCT05395780 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MAX-40279
Description: MAX-40279 capsule will be administered orally
Study NCT05196724 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mentalization Based Therapy MBT
Description: The focus is on improving the core components of secure attachment, particularly by developing the reflective functioning for all professionals working with children in out-of-home care, which is subsequently proposed to increase the psychosocial adjustment of the child and decrease emotional and behavioral problems. MBT treatment consists of up to 12 weekly sessions with the foster parents and child covering three core components: 1) psycho-education about mentalizing, trauma, and attachment for foster parents; 2) support for reflective practice in the professional network, and 3) mentalization-based therapy for the foster family \[41\].
Study NCT05196724 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Usual care
Description: The control group will receive the usual care offered to foster families such as supervision
Study NCT04665791 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Intranasal inoculation with Neisseria lactamica
Description: Lyophilised Neisseria lactamica will be reconstituted and administered to participants intranasally.
Study NCT05449873 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Radiofrequency ablation using combined bipolar and monopolar energy deliver with Triple Cooled-Wet electrodes
Description: Radiofrequency ablation will be performed by using triple cooled-wet electrodes. Two or three electrodes will be places around the tumor under ultrasonography (US)-computed tomography (CT)/magnetic resonance (MR) fusion tool guidance. The electrodes will be cooled with saline, and radiofrequency (RF, bipolar mode and switching monopolar mode) will be applied to two of three electrodes at the same time for about 6 to 30 minutes depending on the tumor size. The temperature will be maintained at 90-100 °C.
Study NCT06029998 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bortezomib
Description: sub-cutaneous injection of bortezomib for 6-8 cycles of treatment.
Study NCT06305546 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Chlorhexidine Gluconate
Description: For two weeks, all individuals were instructed to use pea-sized gel on their gingiva two times a day. To ensure patient compliance, we assigned patients with log sheets to fill daily on whether they used the gel consistently every day twice a day for 2 weeks. Patients were also instructed to return the container of gel on the day of follow-up.
Study NCT06305546 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Metronidazole
Description: For two weeks, all individuals were instructed to use pea-sized gel on their gingiva two times a day. To ensure patient compliance, we assigned patients with log sheets to fill daily on whether they used the gel consistently every day twice a day for 2 weeks. Patients were also instructed to return the container of gel on the day of follow-up.
Study NCT06305546 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: combination gel (chlorhexidine and metronidazole)
Description: For two weeks, all individuals were instructed to use pea-sized gel on their gingiva two times a day. To ensure patient compliance, we assigned patients with log sheets to fill daily on whether they used the gel consistently every day twice a day for 2 weeks. Patients were also instructed to return the container of gel on the day of follow-up.
Study NCT06305546 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: For two weeks, all individuals were instructed to use pea-sized gel on their gingiva two times a day. To ensure patient compliance, we assigned patients with log sheets to fill daily on whether they used the gel consistently every day twice a day for 2 weeks. Patients were also instructed to return the container of gel on the day of follow-up.
Study NCT04892446 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Daratumumab
Description: Administered either SC or IV
Study NCT04892446 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pomalidomide
Description: Administered orally
Study NCT06520423 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Urethral stent tube irrigation
Description: During urethroplasty, a Fr3 ureteral catheter will be placed in the reconstructed urethra, with the proximal end extending approximately 2 cm beyond the urethral wound. The distal end will connect to an F6 single-lumen ureter and a urinary bag. On the second postoperative day, the urethra will be irrigated with 5 ml of saline twice daily. This irrigation routine will continue until the catheter is removed.
Study NCT06520423 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Urinary catheter drainage
Description: During urethroplasty, intraurethral retention of urethral catheters is used to drain urine from the bladder.
Study NCT06520423 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Urinary catheter drainage
Description: During urethroplasty, intraurethral retention of urethral catheters is used to drain urine from the bladder.
Study NCT05396781 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Proflavine
Description: 5-10 ml of proflavine hemisulfate (0.01%) will be sprayed on the esophageal mucosa.
Study NCT05396781 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Mobile, Augmented High Resolution Microendoscope
Description: The marHRME will then be inserted through the endoscope and gently placed against the mucosa. Imaging of abnormal tissues will be performed.
Study NCT05456893 — intervention group
Intervention type: PROCEDURE
Intervention: Procedure: endoscopic biopsy
Description: Per-endoscopic biopsies
Study NCT05456893 — intervention group
Intervention type: PROCEDURE
Intervention: Blood sampling
Description: Blood sampling
Study NCT05456893 — intervention group
Intervention type: PROCEDURE
Intervention: stool sampling
Description: stool sampling
Study NCT03483220 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: MRI brain
Description: 1. Emotion Regulation Questionnaire (ERQ): A 10-item scale designed to measure respondents' tendency to regulate their emotions in two ways: (1) Cognitive Reappraisal and (2) Expressive Suppression. Respondents answer each item on a 7-point Likert-type scale .~UPPS-P Impulsive Behavior Scale- Short form: The UPPS-P impulsivity scale is a 20-item scale designed to assess five distinct personality traits to impulsive behavior: Negative Urgency, Lack of Perseverance, Lack of Premeditation, Positive Urgency and Sensation Seeking .~Magnetic resonance imaging examination:~The MR examination of brain was done using 1.5T MR scanner (Achieva, Philips Medical Systems, The Netherlands) with a 16 channel head coil without using any sedation.
Study NCT04892446 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Description: Administered orally
Study NCT06494514 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: nal-IRI+Oxaliplatin+5-FU/LV+PD-1
Description: These drugs are given on d1, d15, 28 days as one cycle. 6-6 treatment cycles. SBRT is performed in third cycles.
Study NCT06494514 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gemcitabine + albumin-paclitaxel+PD-1
Description: These drugs are given on d1, d8, 21 days as one cycle. 6-6 treatment cycles. SBRT is performed in third cycles.
Study NCT00320580 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: norelgestromin/ethinyl estradiol
Study NCT05231941 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lidocaine IV
Description: Bolus and infusion of lidocaine will be administered
Study NCT05231941 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ropivacaine
Description: Bilateral TAP block will be given to these patients
Study NCT06375720 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Lower frequency, shorter period of Tai Chi Chuan
Description: Participants would take 24-form simplified Tai Chi Chuan 1 hour/session, 3 sessions/week for 12 weeks. There were 10 minutes warm-up, 40 minutes Tai Chi Chuan lesson and 10 minutes cool-down exercises in the Tai Chi Chuan training. Besides, they would also take standard health education 0.5 hour/session, 2 sessions/month for 6 months.
Study NCT06375720 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Higher frequency, shorter period of Tai Chi Chuan
Description: Participants would take 24-form simplified Tai Chi Chuan 1 hour/session, 5 sessions/week for 12 weeks. There were 10 minutes warm-up, 40 minutes Tai Chi Chuan lesson and 10 minutes cool-down exercises in the Tai Chi Chuan training. Besides, they would also take standard health education 0.5 hour/session, 2 sessions/month for 6 months.
Study NCT06375720 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Lower frequency, longer period of Tai Chi Chuan
Description: Participants would take 24-form simplified Tai Chi Chuan 1 hour/session, 3 sessions/week for 24 weeks. There were 10 minutes warm-up, 40 minutes Tai Chi Chuan lesson and 10 minutes cool-down exercises in the Tai Chi Chuan training. Besides, they would also take standard health education 0.5 hour/session, 2 sessions/month for 6 months.
Study NCT06375720 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Higher frequency, longer period of Tai Chi Chuan
Description: Participants would take 24-form simplified Tai Chi Chuan 1 hour/session, 5 sessions/week for 24 weeks. There were 10 minutes warm-up, 40 minutes Tai Chi Chuan lesson and 10 minutes cool-down exercises in the Tai Chi Chuan training. Besides, they would also take standard health education 0.5 hour/session, 2 sessions/month for 6 months.
Study NCT06375720 — intervention group
Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Standard Health Education
Description: Participants would take standard health education 0.5 hour/ session, 2 sessions/month for 6 months.
Study NCT04941365 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: single arm
Description: Blood samples will be collected at baseline(Visit 1), and during therapy at visit 2 (around one month after the treatment starting) and at Visit 3 (around three months after the treatment starting. And, optionally, in case of a disease progression (PD).
Study NCT05612607 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Immunoglobulin replacement therapy (IGRT)
Description: IGRT discontinuation will be dependent on participant's SMB levels. If SMB cells are ≥ 2%, IGRT will be discontinued. If SMB cells are \< 2%, the patient will remain on IGRT and a maximum of 40 mL of blood will be drawn again in 3-6 months to reassess SMB levels and eligibility for IGRT discontinuation.
Study NCT06279403 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Toripalimab
Description: Preoperative Treatment with Toripalimab: Administer 240mg of Toripalimab via intravenous infusion every 3 weeks for a total of 4 cycles.
Study NCT06279403 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Cytoreductive Nephrectomy
Description: Radical Nephrectomy: Complete resection of the tumor and affected kidney within the renal fascia.~Partial Nephrectomy: Complete resection of the tumor while preserving maximal kidney function.~Lymph Node Dissection: For patients with evident enlargement of retroperitoneal lymph nodes preoperatively, perform lymph node dissection at the renal hilum, along the ipsilateral major vessels, and anterior to the ipsilateral major vessels. Lymph node dissection is not required for patients without evident enlargement of retroperitoneal lymph nodes preoperatively.
Study NCT06279403 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Axitinib
Description: Preoperative Treatment with Axitinib: Administer 5mg of axitinib orally twice daily for a duration of 3 months.
Study NCT04892446 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bortezomib
Description: Administered either SC or IV
Study NCT04892446 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carfilzomib
Description: Administered IV
Study NCT04918797 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: COVAXIN
Description: Whole-Virion Inactivated SARS-CoV-2 Vaccine (COVAXIN®)
Study NCT06132750 — intervention group
Intervention type: OTHER
Intervention: No intervention
Description: No intervention
Study NCT05695482 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Neuromuscular training exercises
Description: The 6-week exercise intervention consists of 25-minute group sessions of Neuromuscular training supervised by a researcher.
Study NCT05695482 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Hip abductors muscular strength exercises
Description: The 6-week exercise intervention consists of of 20-minute group sessions of progressive resistance training, supervised by a researcher.
Study NCT06535321 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: vibration training
Description: After modelling, when the vibration platform is closed, all participants of the control group completed the same action as vibration training.
Study NCT06535321 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: vibration training
Description: For the vibration group, vibration training was performed immediately after DOMS modelling.
Study NCT06535321 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Y-shaped kinesio taping
Description: For the kinesio group, Y-shaped kinesio taping was performed 30 min before DOMS modelling.
Study NCT06535321 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Combined vibration training and Y-shaped kinesio taping
Description: For the combined group, the vibration group and kinesio group interventions were performed simultaneously.
Study NCT05343429 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Benzydamine hydrochloride
Description: In BN group,15 ml of 0.15 % Benzydamine hydrochloride (BN) will be dissolved in 15 ml plain water in a sterile container and given to participants before anesthesia for surgery
Study NCT05343429 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Aspirin
Description: In group AP, Aspirin (AP) 600 mg Aspirin tablets dissolved in 30 ml of plain water in a sterile container will be given to participants for gargling before anesthesia for surgery
Study NCT05182892 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Change of stimulation amplitudes in dopaminergic OFF drug state
Description: Change of stimulation amplitudes during experiment in dopaminergic OFF drug state.
Study NCT05860530 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: The test olaparib tablet (T)
Description: The test olaparib tablet (Qilu Pharmaceutical Co., Ltd., Jinan, China) 300mg, every 12 hours
Study NCT05860530 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: The reference olaparib tablet (R)
Description: The reference olaparib tablet (Lynparza®; AstraZeneca PLC, Cambridge, England, UK) 300mg, every 12 hours
Study NCT06549114 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Leniolisib
Description: The doses selected will range from 10 to 70 mg twice daily (BID) (resulting in total daily doses ranging from 20 to 140 mg per day).